Nearly a decade after thousands of homebuyers were left stranded following stalled construction at Jaypee Wish Town, Suraksha Group has announced the completion of 5,989 residential units across 63 towers, offering incremental relief to more than 20,000 buyers awaiting possession. The company, which took control of Jaypee Infratech Limited in 2024 after one of India's most closely watched real estate insolvency resolutions, has received Occupancy Certificates for 31 towers and applied for OCs for another 32 towers.

Major Construction Milestone Achieved

Suraksha Group has successfully completed construction across multiple residential projects within the Wish Town township located along the Noida–Greater Noida Expressway. The company expects approvals for the pending towers over the next couple of months, which will enable further handovers to waiting homebuyers.

Occupancy Certificates Received for 31 Towers

The company has received Occupancy Certificates for 31 towers spread across four residential projects within Wish Town, covering 3,135 units. With these approvals, eligible homebuyers can now proceed towards possession, registration and handover.

Additional Approvals in Pipeline

Suraksha Group has applied for Occupancy Certificates for 32 more towers across Kosmos, Klassic, Kensington Boulevard Apartments, Kensington Park Apartments, Kensington Park Heights and Pebble Court, covering 2,854 units. The company stated that regulatory approvals for these towers are expected over the next few months, which would further accelerate deliveries under the resolution framework.

Background of the Jaypee Wish Town Case

Jaypee Wish Town became a flashpoint in India's real estate crisis after construction halted several years ago, leaving more than 20,000 homebuyers uncertain about delivery timelines despite having invested their life savings. The project evolved into one of the largest cases under the Insolvency and Bankruptcy Code, with homebuyers recognised as financial creditors. Suraksha Group's takeover of Jaypee Infratech in 2024 marked a turning point, with the new management committing to complete the stalled projects under a court-approved resolution plan.

Management Commentary on Progress

Jash Panchamia, Executive Director of Jaypee Infratech Limited, commented on the sustained execution momentum despite regulatory challenges. He noted that despite restrictions imposed on construction activities due to GRAP rules during winter months, the company remains committed to fulfilling customer expectations and delivering as per the timeline outlined in the resolution plan. Panchamia emphasized that construction is progressing at full pace for the remaining towers, with confidence in delivering them in line with the resolution plan.

Significance for Real Estate Sector

The latest construction milestone is being viewed as a gradual but tangible step towards restoring confidence among affected buyers. Market participants noted that sustained progress on approvals and handovers will be crucial to rebuilding trust in one of India's most troubled real estate developments. With nearly 6,000 units now constructed and a pipeline of approvals underway, the gradual resumption of deliveries is expected to serve as a test case for the effectiveness of the IBC framework in resolving large-scale housing distress.

Suraksha Diagnostic Limited , a leading player in the diagnostic services sector, has announced its consolidated financial results for the quarter and six months ended September 30, 2025, showcasing a remarkable improvement in performance.

Revenue Growth

The company reported a significant increase in revenue for Q2, with consolidated revenue from operations rising to ₹7,258.63 lakhs, up from ₹6,675.35 lakhs in the previous quarter. This represents a quarter-on-quarter growth of approximately 8.7%.

Profit Surge

Suraksha Diagnostic experienced a substantial increase in profitability. The consolidated profit after tax for Q2 surged to ₹892.37 lakhs, compared to ₹95.48 lakhs in the prior quarter, marking an impressive growth of about 936%.

Financial Highlights

Six-Month Performance

For the six-month period ended September 30, 2025, Suraksha Diagnostic reported consolidated revenue of ₹12,748.50 lakhs with a profit after tax of ₹1,828.28 lakhs, demonstrating strong overall performance for the first half of the fiscal year.

Key Developments

• The company completed the acquisition of Fetomat Wellness Private Limited on April 8, 2025, acquiring a 63% equity stake for ₹3,73,423 equity shares, making it a subsidiary.
• Basic earnings per share improved significantly to ₹1.72 for the quarter from ₹0.18 in the previous quarter.

Board Meeting and Approval

The Board of Directors met on November 10, 2025, where these unaudited financial results were approved.

The results indicate that Suraksha Diagnostic is experiencing substantial growth in both its top line and bottom line. The dramatic increase in profitability is particularly noteworthy and may suggest successful cost management strategies or higher-margin service offerings.